The concentration of GLP-1 in the sample was calculated by drawing a standard curve
Sharma noted that the study included people who had diabetes in both the group taking the GLP-1 medications and in the comparison group, and they still found a higher incidence of stomach paralysis in those taking the medications, suggesting that diabetes alone wasnt driving the increased risk
The grounds for a lawsuit may include: Failure to warn of vision-related risks Defective drug design Negligence in testing or manufacturing Breach of implied warranty Each of these legal theories requires specific evidence and expert testimony to substantiate, which is why having experienced pharmaceutical injury attorneys is crucial in these complex cases
in International Textbook of Diabetes Mellitus 4th edn Ch 47 (eds DeFronzo, R.A., Ferrannini, E, Alberti, KG, Zimmet, P) (John Wiley & Sons Ltd., 2015)
At $249.97 to $349.97 per month for ongoing treatment (after the first month), this represents a significant recurring expense
They've actually been around for quite a while in that capacity, but subsequent trials showed that, "Hey, these medications have substantial weight loss benefits, too." And so, now some are approved specifically for chronic weight management